Concierge medicine experts Specialdocs Consultants broadened its footprint considerably in 2024, welcoming a record 26 new physician clients to its rapidly growing national network of outstanding ...

Jason Kim has been appointed chief financial officer at Enveda Biosciences, a biotechnology company using artificial ...

Shares of Iovance Biotherapeutics have dropped over 17% so far this week, on course to mark their worst weekly decline since ...

Vertex Pharmaceuticals has a new drug called suzetrigine that it says is nonaddictive and would offer an alternative to painkillers such as oxycodone. The company’s application is pending before the ...

Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the ...

Enveda, a biotechnology company using AI to translate life's chemistry into new medicines, today announced the appointment of ...

A trained pharmaceutical chemist, Lilly was an archetype of the dynamic and multi-talented 19th century American industrialist, who after his military career ... firms such as Vertex have added ...

Ramos, previously Pfizer's senior vice president and global head of BioTherapeutics R&D, has been appointed to the board of ...

Vertex Pharmaceuticals Inc. closed $108.22 short of its 52-week high ($519.88), which the company achieved on November 8th.